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ABSTRACT
Background: Chronic, progressive respiratory
symptoms are associated with great psychological and
emotional impact in patients suffering from interstitial
lung disease (ILD). This single-centre pilot study
evaluated for the first time the safety, feasibility and
efficacy of a Mindfulness Based Stress Reduction
Program (MBSR) in a group of patients with ILD.
Methods: Prospective observational study set in a
university hospital ILD outpatient clinic. Nineteen
patients with different ILDs were recruited 2 months
prior to the start of the 8-week MBSR program and
followed up for 12 months. Primary outcomes were
program safety and feasibility, while secondary
outcomes were changes in moods and stress
(assessed by Profile Of Mood State (POMS) and
Perceived Stress Scale (PSS) questionnaires),
symptoms (Shortness Of Breath (SOB) and Cough And
Sputum Assessment (CASA-Q) questionnaires), lung
function and exercise tolerance at 12 months.
Results: Two patients (10.5%) dropped out in the
observational period before the start of the MBSR
intervention because of non-respiratory causes. All 17
patients who entered the 8-week MBSR program
managed to complete it with an adherence average of
eight sessions of nine. No adverse events related to the
mindfulness training were reported. Statistically
significant improvements in the POMS total score and in
several individual items of POMS and PSS were observed
throughout the study. However, respiratory questionnaire
scores, lung function and exercise tolerance did not
show a significant difference over time.
Conclusions: An MBSR program appears to be safe
and feasible in patients with ILD, and might affect
perceived moods and stress producing a positive and
lasting improvement in several stress-related negative
domains. These findings pave the way to larger (possibly
multicentre), randomised, controlled confirmatory trials.
INTRODUCTION
Interstitial lung diseases (ILDs) are a large
and heterogeneous group of conditions char-
acterised by the diffuse involvement of the
pulmonary interstitial space, with different
patterns of inﬂammation and ﬁbrosis. Many
ILDs are rare entities if considered separ-
ately, although together they account for
one-third of the overall respiratory morbidity.
Chronic ILDs may result in the onset of pul-
monary ﬁbrosis, consisting in the aberrant
deposition of connective tissue (scar) in the
interstitium, possibly leading to impairment
of gas exchange and ultimately death from
respiratory failure. Idiopathic pulmonary
ﬁbrosis (IPF), one of the most common
ILDs, is a speciﬁc form of chronic, progres-
sive interstitial pneumonia of unknown
cause, associated with a poor prognosis with
an average duration from diagnosis to time
of death of 2–3 years.1 2
Chronic, progressive shortness of breath is
nearly universal in patients with ﬁbrotic ILDs,
and may be accompanied by other invalidating
symptoms such as fatigue and cough. These
affect the quality of life of these individuals by
limiting daily life activities, with consequences
on the psychological and emotional levels.
The anxiety related to fear of such symptoms
and consequent loss of self-conﬁdence can
KEY MESSAGES
▸ Interstitial Lung Diseases (ILDs) are charac-
terised by symptoms such as chronic, dyspnea
and cough. These lead to significant psycho-
logical distress, which is scarcely manageable.
▸ This study represents the first attempt to
conduct a Mindfulness-Based Stress Reduction
(MBSR) program in a group of patients with
ILD.
▸ MBSR appears to be a safe and feasible
approach in patients with ILD at different stages
of severity, and it might produce significant
improvement of mood and perception of stress.
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generate further disability, thus triggering a dangerous
vicious circle. Basal dyspnoea is negatively correlated with
quality of life and survival in IPF,3 4 and longitudinal
changes in dyspnoea also predict prognosis.5 However,
despite the clinical signiﬁcance of psychological and emo-
tional disturbance in ILD, there is paucity of data about its
appropriate management; disease-centred pharmaco-
logical therapies have shown little beneﬁt, and comple-
mentary management strategies are frequently needed,
including pulmonary rehabilitation, supplemental oxygen
and opioids.6 Available interventions that could have an
impact on psychological aspects of the disease may include
individual psychological counselling, participation
inpatient support groups or attendance at mindfulness
programs: however, to the best of our knowledge, the
effect of these interventions has never been objectively
measured.
The term ‘mindfulness’ refers to a conscious modality
characterised by a state of mental presence and attention
to the present moment.7 Mindfulness-based techniques
teach the capacity of discriminating thoughts, emotions
and actions with positive effects from those with harmful
effects, increasing the awareness that thoughts are not
reality but only one of its representations.
Mindfulness-Based Stress Reduction (MBSR) is a stan-
dardised mindfulness training program created in 1979
by J Kabat-Zinn to integrate the ancient practices of
meditation with contemporary clinical and psychological
practice.8 Initially, it was developed in an experimental
way to treat groups of patients suffering from chronic
pain,9 but after its standardisation it has been largely
adopted for treating other disorders in the medical and
psychological ﬁelds. In cancer, mindfulness groups were
shown to develop acceptance to the progression of dis-
eases, reduction of fear and avoidance drives.10 Critical
reviews of the evidence of the effect of mindfulness
intervention in this ﬁeld are encouraging,11 12 with clin-
ically relevant implications to alleviate psychological and
physical suffering of persons living with cancer.
MBSR has also demonstrated efﬁcacy in reducing
negative moods and the perceived stress related to dys-
pnoea in asthmatic patients in a pilot study.13 MBSR pro-
grams show efﬁcacy in improving the health-related
quality of life,14 conﬁrming the reliability of these
studies and suggesting long-term follow-up and the use
of active control groups.
Fibrotic lung diseases, often characterised by the
impairment of quality of life due to progressive symp-
toms and worsening emotional status,15 16 may represent
another potential application ﬁeld for MBSR, but has
not currently been investigated.
In this study, we sought to assess the safety and the
feasibility of an MBSR program in a group of patients
affected by different ILDs. We investigated the efﬁcacy of
MBSR on mood, quality of life and also pulmonary func-
tion, as we hypothesised that mindfulness practice might
indirectly trigger a positive, measurable effect on pul-
monary performance and exercise tolerance.
METHODS
Study population and design
Nineteen adult patients were recruited between
November and December 2012 at the Centre for Rare
Lung Diseases of the University Hospital of Modena,
Italy. Inclusion criteria included a conﬁrmed diagnosis
of ILD according to international guidelines. Exclusion
criteria were the inability to express a valid consent, the
inability to perform pulmonary function tests, the use of
long-term oxygen therapy for more than 18 h/day and
the regular practice of meditation or Yoga, as the study
was meant to evaluate the efﬁcacy of mindfulness-based
practice including meditation and Hatha Yoga techni-
ques introduced for the ﬁrst time. Patients of all levels
of disease were included, as the purpose of the study was
to evaluate for the ﬁrst time the feasibility of an MBSR
program in a heterogeneous sample of patients with
ILD. We conducted a prospective, observational study
with a duration of 1 year, comprising three phases: a pre-
intervention observational period (2 months), an inter-
vention period (2 months) during which patients were
trained in the MBSR program, and a postintervention
observational period (8 months; ﬁgure 1).
Ethics and recruitment
The conduct of the study was approved by the Ethics
Committee of Modena, Italy. Twenty-ﬁve patients fol-
lowed up at the Centre for Rare Lung Diseases of the
University Hospital of Modena were invited to take part
and provided with a participant information sheet. An
orientation meeting was also held in order to introduce
candidates to the basic concepts of mindfulness and give
information about the MBSR program. Written
informed consent was collected from all patients who
decided to participate. Overall, six patients declined par-
ticipation, mainly due to the practical difﬁculties they
would have encountered in attending the MBSR
program (many patients lived far away from the centre).
MSBR program
The program was conducted by an MBSR instructor with
a personal history of 20 years of supervised meditation
practice and who was speciﬁcally trained for 2 years in
mindfulness methods at the University of Florence
(Italy). It was divided into eight weekly meetings of
150 min each, to which all the patients were invited to
join as a single group. Meetings were held in a comfort-
able quiet room located inside the hospital building.
Three different techniques were taught in sequence: body
scan focusing on sensations from different parts of the
body, with verbal reminders from the instructor to focus
on abdominal breathing; sitting meditation on a chair with
a straight back, bringing not judgemental awareness of
natural breath and on mental events; light yoga based on
instruction in simple body movements and postures with
controlled breathing. Instructions were given to patients
to continue performing exercises daily at home for
45 min between the weekly meetings and after the
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training programme was completed; patients were also
provided with CDs as a guide for home practice. An
all-day meeting of 7 h between the sixth and the seventh
session completed the course. Overall, the instructor
total contact time was 28 h in 8 weeks.
At the end of the program, patients were asked to con-
tinue practising alone at home every day. To support
patients’ home practice, three quarterly group meetings
of 150 min each were added during the postintervention
observational period.
Outcome measures
The primary outcomes of the study were safety, measured
as the frequency of adverse events related to the practice
of mindfulness techniques, and feasibility, measured as
the rate of dropouts and adherence to the MBSR
program. Other outcomes included changes in mood,
perceived stress and respiratory symptoms (measured by
patient-reported outcomes-questionnaires), change in
lung function (assessed by the rate of relative change
from baseline in forced vital capacity (FVC, % predicted),
and rate of change in Single Breath-Diffusion Lung
Capacity of Carbon Oxide (SB-DLCO) and change in
exercise tolerance measured as changes in the 6 min
walking test (6MWT).
The Proﬁle Of Mood State (POMS) test,17 measuring
the improvement of mood, consists of 40 items clustered
into 6 scales (anger, confusion, depression, fatigue,
tension, Vigour). The Perceived Stress Scale (PSS)18
measures the reduction of stress and consists of 10 items
corresponding to 10 different domains (anger, percep-
tion of control, irritability, self-trust, expectations, efﬁ-
cacy, control of irritation, self-control, uncontrollable
anger, excessive difﬁculties).
The University of California San Diego Shortness Of
Breath Questionnaire (UCSD-SOB)19 and Cough And
Sputum Assessment Questionnaire (CASA-Q),20 respect-
ively assess self-reported shortness of breath and impact of
cough while performing a variety of activities of daily living.
Questionnaires were administered at: enrolment (T0),
at the beginning and at the end of the intervention (T1
and T2), and then at each quarterly meeting until the
end of the follow-up (T3, T4 and T5).
Statistical analysis
For POMS and PSS tests, average scores and changes in
scores were evaluated at the beginning and the end of
the study and also between the different intervals of the
follow-up. For SOB and CASA-Q, total scores for each
patient were calculated and then changes in the scores
were evaluated for statistical signiﬁcance between the
beginning and the end of the study.
Lung function and exercise tolerance were also mea-
sured for each patient approximately every 3 months.
Figure 1 Study design.
SOB, Shortness Of Breath questionnaire; CASA-Q, Cough And Sputum Assessment Questionnaire; POMS, Profile Of Mood
State test; PSS, Perceived Stress Scale; PFT, pulmonary function test; 6MWT, 6 min walk test; MBSR, Mindfulness Based Stress
Reduction program.
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Spirometry and SB-DLCO were performed according to
the available international guidelines,21–23 as well as the
6MWT (distance covered).24The Wilcoxon test was used
to calculate the statistical signiﬁcance of the changes in
the average scores of the POMS and PSS questionnaires
between the different times of the follow-up.
A non-parametric test for repeated measures was used
to assess changes in lung function tests (FVC and
SB-DLCO), 6MWD and questionnaire scores for SOB
and CASA-Q between T0, T2 and T4. To handle missing
answers in items of the SOB and CASA-Q, we chose to
calculate the total score relatively to the maximum the-
oretical score based on the number of answers provided.
RESULTS
Baseline characteristics
The main baseline characteristics are shown in table 1.
Eleven men and eight women (mean age±SD: 65
±8 years) formed a single MBSR training group. The
majority of participants (12 of 19) had a diagnosis of
IPF. The remaining seven patients represented a broad
spectrum of ILD.
Safety and feasibility
Two patients (10.5%) dropped out early from the study
for non-respiratory causes (low back pain and chronic
fatigue, respectively) before they had started the inter-
vention, and were not included in the analysis. The
remaining 17 patients completed the 8-week interven-
tion period. One patient suffered from acute deterior-
ation of clinical conditions during the intervention
period and was admitted into the ward of the clinic of
respiratory diseases, but still managed to attend the
meetings during the period of hospitalisation. There
were no adverse events related to the activities per-
formed, either during the intervention period or during
the follow-up, when patients continued the daily home
practice. The average number of sessions attended per
patient was eight of nine. Adherence to homework was
not recorded.
POMS and PSS
The results for the average scores of POMS and PSS tests
are reported in ﬁgure 2. The POMS test showed signiﬁ-
cant changes in the mean scores indicating an improve-
ment of mood throughout the study period. A total
score was calculated by the addition of all the variables
except for vigour, whose scores were subtracted. A statis-
tically signiﬁcant (z=2.197, p=0.028) reduction can be
found between the start and the end of the study. This
reduction becomes more evident after the intervention
(from T2 on), while a slight trend towards a worsening
of mood was seen during the intervention period.
Between T0 and T5, that is, between enrolment and the
end of the study, the scores for three scales showed a
statistically signiﬁcant reduction: fatigue (z=2.362,
p=0.018), depression (z=2.1977 p=0.028) and anger
(z=1.960, p=0.05). The scale vigour showed a signiﬁcant
increase for the same period (z=2278, p=0.023). The
scale confusion showed a signiﬁcant reduction for the
intervals T1–T2 (z=2.701, p=0.007) and T3–T5 (z=1.979,
p=0.048). Tension showed a steady reduction between
T0 and T5, never reaching statistical signiﬁcance
though.
Perceived stress (PSS score) showed improvement in
all items from T0 and T5. Nevertheless, only four items
showed a statistically signiﬁcant improvement: control of
irritation increasing between T3 and T5 (z=2000,
p=0.048), Uncontrollable Anger parallel decreasing
between T1 and T2 (z=0.680, p=0.046), Anger decreas-
ing between T1 and T4 (z=2.212, p=0.034) and
Irritability decreasing between T1 and T5, respectively
(z=2.111, p=0.046). All changes suggest a positive effect
in terms of reduction of stress. There was also a signiﬁ-
cant decrease in Self-control before the start of the inter-
vention, between T0 and T1 (z=2.008, p=0.045), while it
showed a trend towards improvement thereafter.
Respiratory symptoms questionnaires and pulmonary
function tests
Pulmonary function tests were performed at T0, T2 and
T4, and were analysed together with respiratory symp-
toms scores at the same time points. For each variable,
Table 1 Demographic and clinical features of the
population
Patients enrolled
(N=19)
Age, years (mean±SD) 65±8
M/F, n 11/8
IPF, n 12
Other ILDs, n 7
NSIP 2
RA-ILD 1
Chronic-HP 1
CTD-ILD 1
Asbestosis 1
DIPNECH 1
Lung function tests at baseline
Per cent of predicted FVC
(mean±SD)
82±26
Per cent of predicted SB-DLCO
(mean±SD)
51±19
6MWD at baseline, metres
(mean±SD)
499±87
Dropouts, n (%) 2 (10.5%)
Average number of sessions
attended (of 9)
8
6MWD, 6-min walking test distance; CTD-ILD, connective tissue
disease associated interstitial lung disease; DIPNECH, diffuse
idiopathic pulmonary neuroendocrine cell hyperplasia; FVC, forced
vital capacity; HP, hypersensitivity pneumonitis; ILDs, interstitial
lung diseases; IPF, idiopathic pulmonary fibrosis; NSIP,
non-specific interstitial pneumonia; RA-ILD, rheumatoid arthritis
associated interstitial lung disease; SB-DLCO, single breath
diffusion lung capacity for CO.
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only patients for whom all three time points were avail-
able have been included.
Changes in the % relative scores in the Shortness of
Breath Questionnaire and the Cough and Sputum
Assessment Questionnaire are shown for each patient in
ﬁgure 3. No statistically signiﬁcant differences in ques-
tionnaire scores were observed between different time
points.
Figure 2 Change in average
scores of Profile Of Mood State
test (A) and Perceived Stress
Scale (B) single items between
T0 and T5.
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Similarly, changes in the serial measurements of %
predicted FVC and % predicted SB-DLCO, or in the dis-
tance walked at the 6MWT were not observed, other
than those due to deteriorations associated with the pro-
gression of the underlying ﬁbrotic lung disease
(ﬁgure 4).
DISCUSSION
The ﬁndings of this 1-year prospective observational
pilot study support the feasibility and safety of an MBSR
program in patients affected by ILDs. Feasibility needed
to be established, since one of the main practices of
MBSR involves paying attention to breathing, which
potentially could increase stress in these patients. The
dropout rate was low (10.5%), with two patients with-
drawing from the study during the preintervention
observational period, as they felt unable to attend the
MBSR program regularly. All 17 patients who entered
the program managed to complete the study, attending
an average of eight meetings of the nine scheduled.
This high completion rate is particularly pertinent as
many patients had to travel (in some cases, they lived
hundreds of kilometres away) and the intervention was
held in winter, between January and March, and patients
had to face bad weather. Although adherence to
homework was not recorded (see limitations of the study
below), during the 2 months program and in the
follow-up period a regular daily home practice of
30–45 min was informally reported by 2/3 of the
patients; 1/3 of patients admitted being less regular with
home exercises.
We believe that the reasons for the good adherence to
such a new approach are several. First, the setting chosen
for the MBSR program was a conference room located in
the Clinic for Respiratory Diseases, a familiar place for
the patients. As such, the proximity to a well-known
secure environment and to the familiar and trusted
medical staff (although no doctors were admitted to take
part in the MBSR sessions) might have worked as a facili-
tating factor. Second, the paucity of treatment options for
many ILDs may have encouraged these greatly motivated
patients to search for new approaches of care to improve
their performances and quality of life. Third, feelings of
loneliness and abandonment are often present in
patients with rare diseases, and sharing such an experi-
ence with people affected by the same health problems,
as with dedicated support groups, may be helpful. In fact,
MBSR could represent a complementary strategy for
developing new potential synergies and forming peer
groups, as well as for helping patients acquire self-
awareness and feel more empowered. Furthermore, the
Figure 3 Change in % relative scores of Shortness of Breath (SOB) questionnaire and Cough And Sputum Assessment
Questionnaire (CASA-Q) between T0 and T4 (N=12).
Figure 4 Change in % predicted forced vital capacity FVC (N=13), % predicted SB-DLCO (N=11) and 6 min walking distance
(N=14) between T0 and T4. FVC, forced vital capacity; DLCO, diffusion lung capacity of CO; 6MWD, 6 min walking distance.
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supportive role and empathy with the mindfulness
instructor may act as a non-speciﬁc factor13 improving
program adherence and outcomes.
The results obtained from the questionnaires on
mood and perceived stress showed a potential efﬁcacy of
the MBSR program in improving the emotional status in
these patients.
The improvements in the POMS and PSS question-
naires throughout the 1-year follow-up suggests that the
application of mindfulness techniques may play a role in
helping patients to reduce mood disturbance and in
adjusting better to their incurable disease. The mechan-
ism of action of mindfulness is obviously different from
‘re-framing’ in which thoughts are challenged and
restructured.25 The shift of perspective, named ‘re-per-
ceiving’, is a more reliable mechanism. However, there
might be another way how mindfulness can work, as we
observed in patients an increased capacity to stay
exposed to simple and preordained mental life, disrupt-
ing the strenuous process of holding on themselves and
their world. This attitude of ‘bearing the void’ has a
curious, committed approach; it is effectively sustained
by deep yoga practice, that allow to listen physical sensa-
tions in a new interesting way, not conﬁrming usual
mindsets.
It is noticeable that the improvement of mood had a
constant trend over time (ﬁgure 2) right after the end
of the intervention period. In this period, we recorded
from many patients’ statements about the attractiveness
of the method and their regular practice—developed in
a personal blend of meditation, yoga, body scan and
informal exercises. Therefore, it is possible that the
follow-up periodical meetings worked as a booster for
the patients’ will in pursuing their home practice. It is
not possible, though, to exclude some positive seasonal
inﬂuence on the mood acting as a confounding factor,
as the postintervention observational period covered the
whole spring and summer, potentially bearing a more
positive attitude.
The positive trend in the emotive sphere was not
reﬂected by changes in respiratory symptoms of these
patients, as measured by the Shortness of Breath and
the CASA-Q questionnaires. Lung function and exercise
tolerance were also unaffected. This discrepancy was not
unexpected, however. The respiratory questionnaires
focused on the ability of patients to perform daily life
activities that become limited as the disease progresses,
speciﬁcally dyspnoea and cough. It would be surprising
if an intervention aimed at modifying the perception of
a symptom had such an effect that could even alter the
symptom itself and hence improve physical perfor-
mances. Indeed, it has to be pointed out that there was
no signiﬁcant change in respiratory symptoms over the
study period, which should be considered as a positive
outcome in a 12-month follow-up study including
patients with progressive respiratory diseases.
This pilot study has several limitations. First of all, the
sample size of the study population is small. For the
POMS and the PSS tests, we performed the analysis
across different time points. Although the overall
change in scores between the beginning and the end of
the observation period is consistent, the adoption of
multiple testing carries a potential risk of generating
false positives. This issue might be addressed by larger
studies. ILDs are rare conditions, though, and the
program itself was designed for small groups. As such,
future research requires international multicentre popu-
lations. The advantage of exploring the effect of the
MBSR program in people belonging to different cultural
and social settings would add signiﬁcant strength to the
results.
Second, assessment of mood or stress is very challen-
ging and sensible to the inﬂuence of many confounding
factors: age, comorbidities (physical or psychological)
and external factors (such as seasonality) can easily
affect the perception of mood states and symptoms.
Hence, the adoption of a properly matched control arm
and randomisation would be needed to determine the
real efﬁcacy of the MBSR program in the emotional
ﬁeld.
Another limitation is represented by the substantial
heterogeneity of the population recruited into the study
in terms of disease severity and diagnosis, although the
majority of patients (63%) were affected by IPF. Again,
this limitation is strictly related to the single-centre
design of the study, and larger randomised and possibly
multicentre studies would allow a proper stratiﬁcation of
patients in order to seek how this approach can impact
different stages of severity in speciﬁc conditions.
Finally, in this pilot study, adherence to homework was
not rigorously recorded in diaries, usually adopted for
recording mindfulness practice at home. This was done
in order to not apply pressure on patients with breathing
difﬁculties. Moreover, the sample size was too small for
making adequate comparisons between more and less
compliant patients. Indeed, measures to monitor the
adherence of participants to daily home exercises
should be adopted in conﬁrmatory studies in order to
state with certainty whether pursuing mindfulness prac-
tice after the end of the program results in a consistent,
long-lasting effect.
CONCLUSIONS
This pilot, single-centre, 1-year observational study
demonstrates that MBSR is a feasible and safe approach
in patients affected by ILDs. Our results suggest a positive
effect on patients’moods, lending support for larger con-
trolled studies with a stratiﬁed population to assess the
efﬁcacy of MBSR programs and evaluate their comple-
mentarity with existing dedicated support groups.
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